Drug Profile
Tilmacoxib
Alternative Names: JTE 522Latest Information Update: 23 Sep 2003
Price :
$50
*
At a glance
- Originator Japan Tobacco
- Developer Fujisawa; Japan Tobacco
- Class Antineoplastics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories
- Mechanism of Action Apoptosis stimulants; Cyclo-oxygenase 2 inhibitors; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Familial adenomatous polyposis; Osteoarthritis; Postoperative pain; Rheumatoid arthritis
Most Recent Events
- 23 Sep 2003 Discontinued - Phase-II for Familial adenomatous polyposis in Japan (unspecified route)
- 23 Sep 2003 Discontinued - Phase-II for Osteoarthritis in Japan (PO)
- 23 Sep 2003 Discontinued - Phase-II for Rheumatoid arthritis in Japan (PO)